These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 33020651)

  • 1. Crowding and the shape of COVID-19 epidemics.
    Rader B; Scarpino SV; Nande A; Hill AL; Adlam B; Reiner RC; Pigott DM; Gutierrez B; Zarebski AE; Shrestha M; Brownstein JS; Castro MC; Dye C; Tian H; Pybus OG; Kraemer MUG
    Nat Med; 2020 Dec; 26(12):1829-1834. PubMed ID: 33020651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of the domestic resumption of social production and life under the COVID-19 epidemic.
    Xu X; Wang S; Dong J; Shen Z; Xu S
    PLoS One; 2020; 15(7):e0236387. PubMed ID: 32697812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study.
    Teslya A; Pham TM; Godijk NG; Kretzschmar ME; Bootsma MCJ; Rozhnova G
    PLoS Med; 2020 Jul; 17(7):e1003166. PubMed ID: 32692736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship between the Migrant Population's Migration Network and the Risk of COVID-19 Transmission in China-Empirical Analysis and Prediction in Prefecture-Level Cities.
    Fan C; Cai T; Gai Z; Wu Y
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32290445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial epidemic dynamics of the COVID-19 outbreak in China.
    Kang D; Choi H; Kim JH; Choi J
    Int J Infect Dis; 2020 May; 94():96-102. PubMed ID: 32251789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling and interpreting the COVID-19 intervention strategy of China: A human mobility view.
    Chen H; He J; Song W; Wang L; Wang J; Chen Y
    PLoS One; 2020; 15(11):e0242761. PubMed ID: 33232385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.
    Wu JT; Leung K; Leung GM
    Lancet; 2020 Feb; 395(10225):689-697. PubMed ID: 32014114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early characteristics of the COVID-19 outbreak predict the subsequent epidemic scope.
    Zhang L; Tao Y; Wang J; Ong JJ; Tang W; Zou M; Bai L; Ding M; Shen M; Zhuang G; Fairley CK
    Int J Infect Dis; 2020 Aug; 97():219-224. PubMed ID: 32502662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemic Characteristics of COVID-19 in Four Chinese Cities.
    Hu J; Rao S; Hu X
    Jpn J Infect Dis; 2020 Nov; 73(6):473-475. PubMed ID: 32475873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China.
    Tian H; Liu Y; Li Y; Wu CH; Chen B; Kraemer MUG; Li B; Cai J; Xu B; Yang Q; Wang B; Yang P; Cui Y; Song Y; Zheng P; Wang Q; Bjornstad ON; Yang R; Grenfell BT; Pybus OG; Dye C
    Science; 2020 May; 368(6491):638-642. PubMed ID: 32234804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A versatile web app for identifying the drivers of COVID-19 epidemics.
    Getz WM; Salter R; Luisa Vissat L; Horvitz N
    J Transl Med; 2021 Mar; 19(1):109. PubMed ID: 33726787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
    Peeri NC; Shrestha N; Rahman MS; Zaki R; Tan Z; Bibi S; Baghbanzadeh M; Aghamohammadi N; Zhang W; Haque U
    Int J Epidemiol; 2020 Jun; 49(3):717-726. PubMed ID: 32086938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiscale mobility explains differential associations between the gross domestic product and COVID-19 transmission in Chinese cities.
    Xu XK; Wang L; Pei S
    J Travel Med; 2021 Feb; 28(2):. PubMed ID: 33398326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of haemophilia patients in the COVID-19 pandemic: Experience in Wuhan and Tianjin, two differently affected cities in China.
    Zhang A; Liu W; Poon MC; Liu A; Luo X; Chen L; Hu Q; Yang R
    Haemophilia; 2020 Nov; 26(6):1031-1037. PubMed ID: 32892465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iterative data-driven forecasting of the transmission and management of SARS-CoV-2/COVID-19 using social interventions at the county-level.
    Newcomb K; Smith ME; Donohue RE; Wyngaard S; Reinking C; Sweet CR; Levine MJ; Unnasch TR; Michael E
    Sci Rep; 2022 Jan; 12(1):890. PubMed ID: 35042958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High intensities of population movement were associated with high incidence of COVID-19 during the pandemic.
    Yang H; Chen D; Jiang Q; Yuan Z
    Epidemiol Infect; 2020 Aug; 148():e177. PubMed ID: 32741410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using volunteered geographic information to assess mobility in the early phases of the COVID-19 pandemic: a cross-city time series analysis of 41 cities in 22 countries from March 2nd to 26th 2020.
    Vannoni M; McKee M; Semenza JC; Bonell C; Stuckler D
    Global Health; 2020 Sep; 16(1):85. PubMed ID: 32967691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
    J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Are the Reasons for the Different COVID-19 Situations in Different Cities of China? A Study from the Perspective of Population Migration.
    Zheng Y; Huang J; Yin Q
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33801124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiological characteristics of local COVID-19 epidemics and control experience in routine prevention and control phase in China].
    Zhou Y; Xiao JP; Hu JX; Zhong HJ; Zhang Q; Xie XS; He GH; Rong ZH; Zhan JX; Ma WJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Apr; 43(4):466-477. PubMed ID: 35443299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.